Global Transforming Growth Factor Beta 1 Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Transforming Growth Factor Beta 1 Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Transforming growth factor beta 1 or TGF-β1 is a polypeptide member of the transforming growth factor beta superfamily of cytokines. It is a secreted protein that performs many cellular functions, including the control of cell growth, cell proliferation, cell differentiation, and apoptosis. In humans, TGF-β1 is encoded by the TGFB1 gene

According to our (Global Info Research) latest study, the global Transforming Growth Factor Beta 1 market size was valued at US$ 1681 million in 2023 and is forecast to a readjusted size of USD 3429 million by 2030 with a CAGR of 10.8% during review period.

North America is the largest Transforming Growth Factor Beta 1 market with about 69% market share. Europe is follower, accounting for about 16% market share.The key manufacturers are Roche, Shionogi Ltd, Acceleron Pharma Inc, Genzyme Corp, Isarna Therapeutics GmbH, Scholar Rock, Sirnaomics Inc, Eli Lilly and Co, Formation Biologics Inc, Novartis AG etc.

This report is a detailed and comprehensive analysis for global Transforming Growth Factor Beta 1 market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:

Global Transforming Growth Factor Beta 1 market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2019-2030

Global Transforming Growth Factor Beta 1 market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2019-2030

Global Transforming Growth Factor Beta 1 market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2019-2030

Global Transforming Growth Factor Beta 1 market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2019-2024

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Transforming Growth Factor Beta 1

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Transforming Growth Factor Beta 1 market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Shionogi Ltd, Acceleron Pharma Inc, Genzyme Corp, Isarna Therapeutics GmbH, Scholar Rock, Sirnaomics Inc, Eli Lilly and Co, Formation Biologics Inc, Novartis AG, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

Transforming Growth Factor Beta 1 market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Pirfenidone
Galunisertib
Others

Market segment by Application
IPF
Cancer
Others

Major players covered
Roche
Shionogi Ltd
Acceleron Pharma Inc
Genzyme Corp
Isarna Therapeutics GmbH
Scholar Rock
Sirnaomics Inc
Eli Lilly and Co
Formation Biologics Inc
Novartis AG

Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Transforming Growth Factor Beta 1 product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Transforming Growth Factor Beta 1, with price, sales quantity, revenue, and global market share of Transforming Growth Factor Beta 1 from 2019 to 2024.

Chapter 3, the Transforming Growth Factor Beta 1 competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Transforming Growth Factor Beta 1 breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.

Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Transforming Growth Factor Beta 1 market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Transforming Growth Factor Beta 1.

Chapter 14 and 15, to describe Transforming Growth Factor Beta 1 sales channel, distributors, customers, research findings and conclusion.